Showing 401 - 420 results of 2,166 for search '"cancer registry"', query time: 0.13s Refine Results
  1. 401
  2. 402

    Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends by Hanna M. Peacock, Cindy De Gendt, Geert Silversmit, Sandra Nuyts, Sandra Nuyts, Jan Casselman, Jean-Pascal Machiels, Jean-Pascal Machiels, Francesco Giusti, Bart van Gool, Vincent Vander Poorten, Vincent Vander Poorten, Liesbet Van Eycken

    Published 2023-09-01
    “…We aimed to analyze incidence, clinical stage at presentation, and survival of patients diagnosed with HNC in 2020 in Belgium, considering recent temporal trends.MethodsUsing population-based data from the Belgian Cancer Registry (BCR), we extrapolated 2017-2019 trends in incidence, clinical stage, and 1-year relative survival (1yRS) of HNC to create an expected value for 2020 and compared this to the observed value.ResultsThere were 9.5% fewer HNCs diagnosed in 2020, compared to the predicted incidence. …”
    Get full text
    Article
  3. 403
  4. 404

    Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries by Rafael Cardoso, Feng Guo, Thomas Heisser, Harlinde De Schutter, Nancy Van Damme, Mef Christina Nilbert, Jane Christensen, Anne-Marie Bouvier, Véronique Bouvier, Guy Launoy, Anne-Sophie Woronoff, Mélanie Cariou, Michel Robaszkiewicz, Patricia Delafosse, Florence Poncet, Paul M. Walsh, Carlo Senore, Stefano Rosso, Valery E.P.P. Lemmens, Marloes A.G. Elferink, Sonja Tomšič, Tina Žagar, Arantza Lopez de Munain Marques, Rafael Marcos-Gragera, Montse Puigdemont, Jaume Galceran, Marià Carulla, Antonia Sánchez-Gil, María-Dolores Chirlaque, Michael Hoffmeister, Hermann Brenner

    Published 2022-10-01
    “…Methods: Data from CRC patients were obtained from 16 population-based cancer registries in nine European countries. We included patients with cancer diagnosed from the year organised CRC screening programmes were introduced until the most recent year with available data at the time of analysis, whose ages at diagnosis fell into the age groups targeted by screening. …”
    Get full text
    Article
  5. 405

    Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany by Christine Eisfeld, Hiltraud Kajüter, Lennart Möller, Ina Wellmann, Evgenii Shumilov, Andreas Stang

    Published 2023-04-01
    “…Methods Age-standardised and age group-specific relative survival (RS) of MM patients aged < 80 years at diagnosis was estimated for consecutive time periods from 2000–2019 using data from the Cancer Registry of North Rhine-Westphalia in Germany. …”
    Get full text
    Article
  6. 406

    Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany by Nina Grundmann, Sven Voigtländer, Amir Hakimhashemi, Ulrich‐Frank Pape, Martin Meyer, Jacqueline Müller‐Nordhorn

    Published 2023-10-01
    “…Methods Incident cases of GEP‐NEN diagnosed between 2005 and 2019 were retrieved from the prospective, population‐based Bavarian Cancer Registry. GEP‐NEN were divided in their histologic subtypes, that is, neuroendocrine tumors (NET) G1, NET G2/G3, other NET versus small‐cell neuroendocrine carcinoma (NEC), large‐cell NEC, and other NEC. …”
    Get full text
    Article
  7. 407

    Analysis of the Consumption of Non-Oncological Medicines: A Methodological Study on Patients of the Ada Cohort by Giulio Barigelletti, Giovanna Tagliabue, Sabrina Fabiano, Annalisa Trama, Alice Bernasconi, Claudio Tresoldi, Viviana Perotti, Andrea Tittarelli, Ada Working Group

    Published 2021-08-01
    “…Records of medicines present in the pharmaceutical flows collected by eight Lombardy cancer registries and used by patients with any type of cancer were extracted for the year 2012. …”
    Get full text
    Article
  8. 408

    Survival of patients with cancers of the female genital organs in Poland, 2000–2019 by Florentino Luciano Caetano dos Santos, Urszula Wojciechowska, Irmina Maria Michalek, Joanna Didkowska

    Published 2023-05-01
    “…Data were obtained from the Polish National Cancer Registry. We estimated age-standardized 5- and 10-year net survival (NS) with the life table method and the Pohar-Perme estimator using the International Cancer Survival Standard weights. …”
    Get full text
    Article
  9. 409
  10. 410

    Socio-Economic Position, Cancer Incidence and Stage at Diagnosis: A Nationwide Cohort Study in Belgium by Michael Rosskamp, Julie Verbeeck, Sylvie Gadeyne, Freija Verdoodt, Harlinde De Schutter

    Published 2021-02-01
    “…<i>Methods</i>: The 2001 census was linked to the nationwide Belgian Cancer Registry for cancer diagnoses between 2004 and 2013. …”
    Get full text
    Article
  11. 411

    The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates by Gilles Macq, Geert Silversmit, Freija Verdoodt, Liesbet Van Eycken

    Published 2023-04-01
    “…The results are based on data of a population-based cancer registry with a relatively recent onset (2004).…”
    Get full text
    Article
  12. 412
  13. 413
  14. 414

    Trends of colorectal cancer incidence according to age, anatomic site, and histological subgroup in Bavaria: A registry-based study by Sven Voigtländer, Amir Hakimhashemi, Nina Grundmann, Franziska Rees, Martin Meyer, Hana Algül, Jacqueline Müller-Nordhorn

    Published 2022-09-01
    “…There is a lack of studies distinguishing between histological subgroups, especially from Europe.MethodsUsing data from the Bavarian Cancer Registry, we analyzed incidence trends in colorectal cancer by age (20–29, 30–39, 40–49, and 50 years and above), anatomic site (colon without appendix, appendix, and rectum), and histological subgroup (adenocarcinoma and neuroendocrine neoplasm) from 2005 to 2019. …”
    Get full text
    Article
  15. 415
  16. 416
  17. 417

    National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens by Shama Virani, Surichai Bilheem, Wasan Chansaard, Imjai Chitapanarux, Karnchana Daoprasert, Somsak Khuanchana, Atit Leklob, Donsuk Pongnikorn, Laura S. Rozek, Surattaya Siriarechakul, Krittika Suwanrungruang, Sukit Tassanasunthornwong, Patravoot Vatanasapt, Hutcha Sriplung

    Published 2017-08-01
    “…We provide a comprehensive assessment of these five cancers nationally and subnationally, with trend analysis, projections, and number of cases expected for the year 2025 using cancer registry data. We found that breast (average annual percent change (AAPC): 3.1%) and colorectal cancer (female AAPC: 3.3%, male AAPC: 4.1%) are increasing while cervical cancer (AAPC: −4.4%) is decreasing nationwide. …”
    Get full text
    Article
  18. 418

    Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal by Filipa Alves da Costa, Adriana Ramos, Catarina Bernardo, Fábio Cardoso Borges, Ana Costa Miranda, the ROR-Sul network

    Published 2023-04-01
    “…Data were extracted from a cancer registry (ROR-Sul) covering 4,800,000 inhabitants (46% of the Portuguese population) and included a total of 789 individuals meeting eligibility criteria. …”
    Get full text
    Article
  19. 419

    Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study by L. Lukas Löfling, Nathalie C. Støer, Bettina Kulle Andreassen, Giske Ursin, Edoardo Botteri

    Published 2023-08-01
    “…Women aged ≥ 50 years and diagnosed with BC in 2004–2017, who survived ≥ 12 months after diagnosis (follow-up started 12 months after diagnosis), were identified in the Cancer Registry of Norway. The Norwegian Prescription Database provided information on prescriptions. …”
    Get full text
    Article
  20. 420